Kupffer cell-expressed membrane-bound TNF mediates melphalan hepatotoxicity via activation of both TNF receptors

Journal of Immunology

Volumn 175, Issue 6, 2005, Pages 4076-4083

  Kresse, Matthias ^a   Latta, Markus ^a   Künstle, Gerald ^a   Riehle, Hans Martin ^b   Van Rooijen, Nico ^c   Hentze, Hannes ^a   Tiegs, Gisa ^d   Biburger, Markus ^d   Lucas, Rudolf ^a   Wendel, Albrecht ^a  

^a UNIVERSITY OF KONSTANZ   (Germany)

^b UNIVERSITY HOSPITAL ZURICH   (Switzerland)

^c UNIVERSITY OF AMSTERDAM   (Netherlands)

^d UNIVERSITY OF ERLANGEN NUREMBERG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CASPASE; CD95 RECEPTOR; MELPHALAN; RECEPTOR; TUMOR NECROSIS FACTOR; TUMOR NECROSIS FACTOR ALPHA CONVERTING ENZYME; TUMOR NECROSIS FACTOR RECEPTOR; TUMOR NECROSIS FACTOR RECEPTOR 1; TUMOR NECROSIS FACTOR RECEPTOR 2; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; ARTICLE; CELL CONTACT; CELL DEATH; CONTROLLED STUDY; KUPFFER CELL; LIVER CANCER; LIVER CELL; LIVER PERFUSION; LIVER TOXICITY; MALE; MEMBRANE BINDING; MOUSE; NONHUMAN; PRIORITY JOURNAL;

EID: 23844446098     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.175.6.4076     Document Type: Article

References (43)

1. Weiss, L., E. Grundmann, J. Torhorst, F. Hartveit, I. Moberg, M. Eder, C. M. Fenoglio-Preiser, J. Napier, C. H. Horne, M. J. Lopez, et al. 1986. Haematogenous metastatic patterns in colonic carcinoma: an analysis of 1541 necropsies. J. Pathol. 150: 195-203.
2. Rajpal, S., R. Moore, and C. P. Karakousis. 1983. Survival in metastatic ocular melanoma. Cancer 52: 334-336.
3. Frankfurt, O. S. 1987. Detection of DNA damage in individual cells by flow cytometric analysis using anti-DNA monoclonal antibody. Exp. Cell Res. 170: 369-380.
4. Garcia, S. T., A. McQuillan, and L. Panasci. 1988. Correlation between the cytotoxicity of melphalan and DNA crosslinks as detected by the ethidium bromide fluorescence assay in the F1 variant of B16 melanoma cells. Biochem. Pharmacol. 37: 3189-3192.
5. Masta, A., P. J. Gray, and D. R. Phillips. 1995. Nitrogen mustard inhibits transcription and translation in a cell free system. Nucleic Acids Res. 23: 3508-3515.
6. Lienard, D., A. M. Eggermont, H. S. Koops, B. Kroon, G. Towse, S. Hiemstra, P. Schmitz, J. Clarke, G. Steinmann, F. Rosenkaimer, and F. J. Lejeune. 1999. Isolated limb perfusion with tumour necrosis factor α and melphalan with or without interferon γ for the treatment of in-transit melanoma metastases: a multicentre randomized phase II study. Melanoma Res. 9: 491-502.
7. Fraker, D. L., H. R. Alexander, M. Andrich, and S. A. Rosenberg. 1996. Treatment of patients with melanoma of the extremity using hyperthermic isolated limb perfusion with melphalan, tumor necrosis factor, and interferon γ: results of a tumor necrosis factor dose-escalation study. J. Clin. Oncol. 14: 479-489.
8. Eggermont, A. M., H. Schraffordt Koops, J. M. Klausner, B. B. Kroon, P. M. Schlag, D. Lienard, A. N. van Geel, H. J. Hoekstra, I. Meller, O. E. Nieweg, et al. 1996. Isolated limb perfusion with tumor necrosis factor and melphalan for limb salvage in 186 patients with locally advanced soft tissue extremity sarcomas: the cumulative multicenter European experience. Ann. Surg. 224: 756-764; discussion 764-765.
9. Eggermont, A. M., H. Schraffordt Koops, D. Lienard, B. B. Kroon, A. N. van Geel, H. J. Hoekstra, and F. J. Lejeune. 1996. Isolated limb perfusion with high-dose tumor necrosis factor α in combination with interferon γ and melphalan for nonresectable extremity soft tissue sarcomas: a multicenter trial. J. Clin. Oncol. 14: 2653-2665.
10. Lans, T. E., D. L. Bartlett, S. K. Libutti, M. F. Gnant, D. J. Liewehr, D. J. Venzon, E. M. Turner, and H. R. Alexander. 2001. Role of tumor necrosis factor on toxicity and cytokine production after isolated hepatic perfusion. Clin. Cancer Res. 7: 784-790.
11. Alexander, H. R., Jr., D. L. Bartlett, and S. K. Libutti. 2000. Current status of isolated hepatic perfusion with or without tumor necrosis factor for the treatment of unresectable cancers confined to liver. Oncologist 5: 416-424.
12. Weinreich, D. M., and H. R. Alexander. 2002. Transarterial perfusion of liver metastases. Semin. Oncol. 29: 136-144.
13. Alexander, H. R., Jr., D. L. Bartlett, S. K. Libutti, D. L. Fraker, T. Moser, and S. A. Rosenberg. 1998. Isolated hepatic perfusion with tumor necrosis factor and melphalan for unresectable cancers confined to the liver. J. Clin. Oncol. 16: 1479-1489.
14. Fausto, N. 2000. Liver regeneration. J. Hepatol. 32: 19-31.
15. Rudiger, H. A., and P. A. Clavien. 2002. Tumor necrosis factor α, but not Fas, mediates hepatocellular apoptosis in the murine ischemic liver. Gastroenterology 122: 202-210.
16. Leist, M., F. Gantner, I. Bohlinger, P. G. Germann, G. Tiegs, and A. Wendel. 1994. Murine hepatocyte apoptosis induced in vitro and in vivo by TNF-α requires transcriptional arrest. J. Immunol. 153: 1778-1788.
17. Leist, M., F. Gantner, S. Jilg, and A. Wendel. 1995. Activation of the 55 kDa TNF receptor is necessary and sufficient for TNF-induced liver failure, hepatocyte apoptosis, and nitrite release. J. Immunol. 154: 1307-1316.
18. Seglen, P. O. 1973. Preparation of rat liver cells. 3. Enzymatic requirements for tissue dispersion. Exp. Cell Res. 82: 391-398.
19. Van Rooijen, N., and A. Sanders. 1994. Liposome mediated depletion of macrophages: mechanism of action, preparation of liposomes and applications. J. Immunol. Methods 174: 83-93.
20. Lucas, R., P. Juillard, E. Decoster, M. Redard, D. Burger, Y. Donati, C. Giroud, C. Monso-Hinard, T. De Kesel, W. A. Buurman, et al. 1997. Crucial role of tumor necrosis factor (TNF) receptor 2 and membrane-bound TNF in experimental cerebral malaria. Eur. J. Immunol. 27: 1719-1725.
21. Lucas, R., K. Heirwegh, A. Neirynck, L. Remels, H. Van Heuverswyn, and P. De Baetselier. 1990. Generation and characterization of a neutralizing rat anti-rmTNF-α monoclonal antibody. Immunology 71: 218-223.
22. Spriggs, D. R., M. L. Sherman, H. Michie, K. A. Arthur, K. Imamura, D. Wilmore, E. Frei, 3rd, and D. W. Kufe. 1988. Recombinant human tumor necrosis factor administered as a 24-hour intravenous infusion: a phase I and pharmacologic study. J. Natl. Cancer Inst. 80: 1039-1044:
23. Alexander, H. R., Jr., S. K. Libutti, D. L. Bartlett, J. F. Pingpank, K. Kranda, C. Helsabeck, and T. Beresnev. 2002. Hepatic vascular isolation and perfusion for patients with progressive unresectable liver metastases from colorectal carcinoma refractory to previous systemic and regional chemotherapy. Cancer 95: 730-736.
24. Hentze, H., M. Latta, G. Künstle, S. Dhakshinamoorthy, N. Y. Ng, A. G. Porter, and A. Wendel. 2004. The topoisomerase inhibitor Camptothecin sensitizes mouse hepatocytes in vitro and in vivo to TNF-mediated apoptosis. Hepatology 39: 1311-1320.
25. Yamada, Y., E. M. Webber, I. Kirillova, J. J. Peschon, and N. Fausto. 1998. Analysis of liver regeneration in mice lacking type 1 or type 2 tumor necrosis factor receptor: requirement for type 1 but not type 2 receptor. Hepatology 28: 959-970.
26. Yamada, Y., and N. Fausto. 1998. Deficient liver regeneration after carbon tetrachloride injury in mice lacking type 1 but not type 2 tumor necrosis factor receptor. Am. J. Pathol. 152: 1577-1589.
27. Knight, B., G. C. Yeoh, K. L. Husk, T. Ly, L. J. Abraham, C. Yu, J. A. Rhim, and N. Fausto. 2000. Impaired preneoplastic changes and liver tumor formation in tumor necrosis factor receptor type 1 knockout mice. J. Exp. Med. 192: 1809-1818.
28. Luster, M. I., P. P. Simeonova, R. M. Gallucci, A. Bruccoleri, M. E. Blazka, B. Yucesoy, and J. M. Matheson. 2000. The role of tumor necrosis factor α in chemical-induced hepatotoxicity. Ann. NY Acad. Sci. 919: 214-220.
29. Simeonova, P. P., R. M. Gallucci, T. Hulderman, R. Wilson, C. Kommineni, M. Rao, and M. I. Luster. 2001. The role of tumor necrosis factor α in liver toxicity, inflammation, and fibrosis induced by carbon tetrachloride. Toxicol. Appl. Pharmacol. 177: 112-120.
30. Enomoto, N., Y. Takei, M. Hirose, K. Ikejima, H. Miwa, T. Kitamura, and N. Sato. 2002. Thalidomide prevents alcoholic liver injury in rats through suppression of Kupffer cell sensitization and TNF-α production. Gastroenterology 123: 291-300.
31. Sharma, R. P., N. Bhandari, R. T. Riley, K. A. Voss, and F. I. Meredith. 2000. Tolerance to fumonisin toxicity in a mouse strain lacking the P75 tumor necrosis factor receptor. Toxicology 143: 183-194.
32. Ulich, T. R., K. Z. Guo, B. Irwin, D. G. Remick, and G. N. Davatelis. 1990. Endotoxin-induced cytokine gene expression in vivo. II. Regulation of tumor necrosis factor and interleukin-1 α/β expression and suppression. Am. J. Pathol. 137: 1173-1185.
33. Black, R. A., C. T. Rauch, C. J. Kozlosky, J. J. Peschon, J. L. Slack, M. F. Wolfson, B. J. Castner, K. L. Stocking, P. Reddy, S. Srinivasan, et al. 1997. A metalloproteinase disintegrin that releases tumour-necrosis factor α from cells. Nature 385: 729-733.
34. Moss, M. L., S. L. Jin, M. E. Milla, D. M. Bickett, W. Burkhart, H. L. Carter, W. J. Chen, W. C. Clay, J. R. Didsbury, D. Hassler, et al. 1997. Cloning of a disintegrin metalloproteinase that processes precursor tumour-necrosis factor α. Nature 385: 733-736.
35. Boldin, M. P., E. E. Varfolomeev, Z. Pancer, I. L. Mett, J. H. Camonis, and D. Wallach. 1995. A novel protein that interacts with the death domain of Fas/APO1 contains a sequence motif related to the death domain. J. Biol. Chem. 270: 7795-7798.
36. Tartaglia, L. A., T. M. Ayres, G. H. Wong, and D. V. Goeddel. 1993. A novel domain within the 55 kd TNF receptor signals cell death. Cell 74: 845-853.
37. Probert, L., K. Akassoglou, G. Kassiotis, M. Pasparakis, L. Alexopoulou, and G. Kollias. 1997. TNF-α transgenic and knockout models of CNS inflammation and degeneration. J. Neuroimmunol. 72: 137-141.
38. Akassoglou, K., L. Probert, G. Kontogeorgos, and G. Kollias. 1997. Astrocyte-specific but not neuron-specific transmembrane TNF triggers inflammation and degeneration in the central nervous system of transgenic mice. J. Immunol. 158: 438-445.
39. Akassoglou, K., E. Douni, J. Bauer, H. Lassmann, G. Kollias, and L. Probert. 2003. Exclusive tumor necrosis factor (TNF) signaling by the p75TNF receptor triggers inflammatory ischemia in the CNS of transgenic mice. Proc. Natl. Acad. Sci. USA 100: 709-714.
40. Georgopoulos, S., D. Plows, and G. Kollias. 1996. Transmembrane TNF is sufficient to induce localized tissue toxicity and chronic inflammatory arthritis in transgenic mice. J. Inflamm. 46: 86-97.
41. Küsters, S., G. Tiegs, L. Alexopoulou, M. Pasparakis, E. Douni, G. Künstle, H. Bluethmann, A. Wendel, K. Pfizenmaier, G. Kollias, and M. Grell. 1997. In vivo evidence for a functional role of both tumor necrosis factor (TNF) receptors and transmembrane TNF in experimental hepatitis. Eur. J. Immunol. 27: 2870-2875.
42. Wajant, H., K. Pfizenmaier, and P. Scheurich. 2003. Tumor necrosis factor signaling. Cell Death Differ. 10: 45-65.
43. Van Molle, W., B. Wielockx, T. Mahieu, M. Takada, T. Taniguchi, K. Sekikawa, and C. Libert. 2002. HSP70 protects against TNF-induced lethal inflammatory shock. Immunity 16: 685-695.